06Jan/14

Juan Sanabria, MD, MSc, FRCSC, FACS, Joins Cancer Treatment Centers of … – PR Newswire (press release)

Juan Sanabria, MD, MSc, FRCSC, FACS, Joins Cancer Treatment Centers of
PR Newswire (press release)
St Michael’s Hospital. Dr. Sanabria also completed a fellowship in the Epidemiology Unit G.I. Cancer Registry at Mount Sinai Hospital, as well as a fellowship in the HPB and Transplant Surgery Multi-Organ Transplant Unit at the University of Toronto.

06Jan/14

PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from … – MarketWatch


Drug Discovery & Development

PIXUVRI® (pixantrone) Receives Positive Final Appraisal Determination from
MarketWatch
showing PIXUVRI’s cost effectiveness and recommended the treatment as an option for certain people with histologically confirmed aggressive B-cell NHL who have previously received rituximab and are receiving PIXUVRI as a third- or fourth-line
UK’s NICE Issues Final Appraisal Determination on CTI Lymphoma DrugDrug Discovery & Development
Cell Therapeutics Inc (CTIC): Is Cell Therapeutics Turning Over A New Leaf In Seeking Alpha

all 22 news articles »